Survival benefits in colorectal adenocarcinoma with the use of metformin among a black diabetic inner city population
{{output}}
We assessed the association of metformin use with survival in colorectal cancer in a population consists mostly of African-American and Afro-Caribbean patients. We identified 585 colorectal cancer patients, 167 (28.6%) and 418 (71.5%) were as diabetic (DM) and... ...
